Breast Cancer

Showing NaN - NaN of 139

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Pembrolizumab)

Not yet recruiting
  • Breast Cancer
  • Jonesboro, Arkansas
  • +142 more
Oct 31, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Duarte, California
  • +111 more
Oct 23, 2023

Breast Tumors, Breast Tumor Female, Cancer, Breast Trial in Montréal (Thoracic paravertebral block multiple (3) injections,

Recruiting
  • Breast Neoplasms
  • +3 more
  • Thoracic paravertebral block multiple (3) injections
  • Thoracic paravertebral block single injection
  • Montréal, Quebec, Canada
    CIUSSS de l'Est de l'Île de Montréal
Feb 3, 2023

Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)

Completed
  • Breast Cancer
  • Stage IV Breast Cancer
  • palliative surgery
  • +3 more
  • Mobile, Alabama
  • +376 more
Jan 6, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Paclitaxel, Nab-paclitaxel)

Recruiting
  • Breast Cancer
  • Duarte, California
  • +260 more
Jan 19, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Capecitabine)

Recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +165 more
Jan 17, 2023

Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Trastuzumab Deruxtecan
  • +5 more
  • Springdale, Arkansas
  • +203 more
Jan 13, 2023

Breast Cancer Trial in Worldwide (Inavolisib, Placebo, Palbociclib)

Recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +228 more
Jan 10, 2023

Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alaska
  • +275 more
Dec 13, 2022

Developing Cardiotoxicity After Receiving Chemotherapy for

Recruiting
  • Breast Cancer
  • +2 more
  • Cardiac Imaging
  • Data Collection
  • Montréal, Quebec, Canada
  • +2 more
Dec 20, 2022

Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +172 more
Dec 1, 2022

Breast Cancer Trial in Worldwide (Olaparib, Placebo)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alabama
  • +698 more
Nov 25, 2022

Post-mastectomy Pain Syndrome, Breast Cancer, Pain, Postoperative Trial in Canada (Lidocaine 20mg/ml, Placebo)

Recruiting
  • Post-mastectomy Pain Syndrome
  • +3 more
  • Lidocaine 20mg/ml
  • Placebo
  • Calgary, Alberta, Canada
  • +11 more
Nov 24, 2022

Local Recurrence Following Breast Conserving Surgery and

Active, not recruiting
  • Breast Cancer
    • Calgary, Alberta, Canada
    • +26 more
    Sep 19, 2022

    Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)

    Enrolling by invitation
    • Ovarian Cancer
    • Breast Cancer
    • Boca Raton, Florida
    • +98 more
    Aug 22, 2022

    Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)

    Recruiting
    • Breast Cancer
    • Bowral, New South Wales, Australia
    • +37 more
    Aug 8, 2022

    Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

    Active, not recruiting
    • Breast Cancer
    • Chandler, Arizona
    • +166 more
    Jul 21, 2022

    Breast Cancer Trial in Worldwide (biological, drug, other, procedure)

    Active, not recruiting
    • Breast Cancer
    • nivolumab
    • +6 more
    • Mobile, Alabama
    • +255 more
    Jul 21, 2022

    Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)

    Active, not recruiting
    • Breast Cancer
    • Tucson, Arizona
    • +167 more
    Jul 19, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

    Active, not recruiting
    • Breast Cancer
    • Anchorage, Alaska
    • +495 more
    Jun 15, 2022

    HER2 Low and Describe SoC, Treatment Patterns, and Outcome in

    Completed
    • Breast Cancer
    • None (Observational study)
    • Pittsburgh, Pennsylvania
    • +12 more
    May 25, 2022

    Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))

    Active, not recruiting
    • Breast Cancer
    • Aurora, Colorado
    • +132 more
    Apr 26, 2022

    Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)

    Active, not recruiting
    • Breast Cancer
    • Amcenestrant-matching placebo
    • +5 more
    • Daphne, Alabama
    • +299 more
    May 5, 2022

    Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

    Active, not recruiting
    • Breast Cancer
    • Trastuzumab deruxtecan (T-DXd)
    • Ado-trastuzumab emtansine (T-DM1)
    • Los Angeles, California
    • +163 more
    Apr 1, 2022